{
    "title": "FDA approves Eli Lilly drug for thyroid, lung cancers driven by a genetic mutation",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8302263/FDA-approves-Eli-Lilly-drug-thyroid-lung-cancers-driven-genetic-mutation.html",
    "date": "2020-05-08",
    "keywords": [
        "drug",
        "cancer",
        "oncology",
        "carl",
        "odonnell",
        "lung",
        "thyroid",
        "mutation",
        "selpercatinib",
        "ret",
        "retevmo",
        "treatment",
        "division",
        "approval",
        "mishra",
        "food",
        "administration",
        "purchase",
        "gene",
        "part",
        "trend",
        "body",
        "disease",
        "price",
        "brand",
        "name",
        "head",
        "lillys",
        "enzyme",
        "cell",
        "growth",
        "regardless",
        "potential",
        "payoff",
        "loxo",
        "move",
        "presence",
        "help",
        "patent",
        "bigselling",
        "coronavirus",
        "epidemic",
        "ability",
        "country",
        "travel",
        "spread",
        "virus",
        "access",
        "phone",
        "video",
        "conference",
        "launching",
        "world",
        "drugmaker",
        "bristol",
        "launch",
        "sclerosis",
        "zeposia",
        "ozanimod",
        "pipeline",
        "market",
        "acquisition",
        "vitrakvi",
        "bayer",
        "ag",
        "year",
        "research",
        "company",
        "core",
        "blockbuster",
        "humalog",
        "dysfunction",
        "cialis",
        "face",
        "competition",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}